TOPOTECAN VERSUS TREOSULFAN IN EARLY RECURRENT OVARIAN CANCER AFTER PRIMARY PLATINUM/ PACLITAXEL CHEMOTHERAPY. A PROSPECTIVE RANDOMIZED PHASE III TRIAL OF THE AGO OVARIAN CANCER STUDY GROUP
TOPOTECAN VERSUS TREOSULFAN IN EARLY RECURRENT OVARIAN CANCER AFTER PRIMARY PLATINUM/ PACLITAXEL CHEMOTHERAPY. A PROSPECTIVE RANDOMIZED PHASE III TRIAL OF THE AGO OVARIAN CANCER STUDY GROUP